Testing effectiveness (Phase 2)WithdrawnNCT02977689What this trial is testingTrial of IDH305 in IDH1 Mutant Grade II or III GliomaWho this might be right forGlioma NYU Langone Health
Testing effectiveness (Phase 2)Looking for participantsNCT06161974What this trial is testingStudy of Olutasidenib and Temozolomide in HGGWho this might be right forHigh Grade GliomaAstrocytomaAstrocytoma, Grade III+16 more Rigel Pharmaceuticals 60